Mahacef 100mg Dry Syrup contains Cefixime, a third-generation cephalosporin antibiotic, at a concentration of 100mg per 5ml when reconstituted. It is indicated for the treatment of a variety of bacterial infections caused by susceptible organisms, including respiratory tract infections, urinary tract infections, otitis media, pharyngitis, and gonorrhea. Cefixime exerts its antibacterial effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. This formulation is particularly suitable for pediatric patients and those who have difficulty swallowing tablets. Mahacef 100mg Dry Syrup should be reconstituted with the specified amount of water before administration, ensuring proper dosing accuracy. The dosage and duration of therapy depend on the type and severity of the infection, as well as the patient’s age and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, may occur and necessitate discontinuation of therapy. It is important to complete the full prescribed course to prevent the development of antibiotic resistance. Mahacef is contraindicated in patients with known hypersensitivity to cephalosporins or penicillins. Caution is advised in patients with renal impairment.